Skip to main content

Molecular Pathology of Testicular Cancer

  • Chapter
  • First Online:
Molecular Surgical Pathology

Abstract

All cell types from the testis can give rise to neoplasms. It is of relevance to distinguish germ cell tumors and nongerm cell tumors. Understanding the existence of the various types of neoplasms of the testis, and getting insight into their pathogenesis, requires knowledge about the normal anatomy and physiology of both the developing and mature testis. The germ cell tumors represent the most frequent neoplasm, followed by the sex cord–stromal tumors (Leydig cell and Sertoli cell tumors) and others. Based on morphological criteria, germ cell tumors are subdivided into seminoma, embryonal carcinoma, yolk sac tumor, teratoma, choriocarcinoma, and spermatocytic tumor. Alternatively, a classification system has been proposed, in which age at presentation, pattern of genomic imprinting, cell of origin, chromosomal constitution, as well as representative animal model(s) are included. Within the testis, three of these subtypes can be found, each with their own clinical and pathological characteristics. Based on this recognition, an informative set of diagnostic markers has been developed, proven to be of value in a clinical setting. These can even be applied for early diagnosis, i.e., in the preinvasive stage, in specific groups of individuals known to be at risk. This will possibly prevent the need for systemic treatment, irradiation, or chemotherapy at a relatively young age, known to have significant side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Suggested Reading

  • Almstrup K, Lobo J, Mørup N, et al. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours. Nat Rev Urol. 2020;17:201–13.

    Article  CAS  PubMed  Google Scholar 

  • Al-Obaidy KI, Chovanec M, Cheng L. Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance. Expert Rev Anticancer Ther. 2020;20:75–9.

    Article  CAS  PubMed  Google Scholar 

  • Berney DM, Cree I, Rao V, et al. An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology. 2022;81:459–66.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cheng L, Sung MT, Cossu-Rocca P, et al. LHJ: OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol. 2007;211:1–9.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Lyu B, Roth LM. Perspectives on testicular germ cell neoplasms. Hum Pathol. 2017;59:10–25.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Albers P, Berney DM, et al. Testicular Cancer. Nat Rev Dis Primers. 2018;4:29.

    Article  PubMed  Google Scholar 

  • Cheng L, MacLennan GT, Bostwick DG, editors. Urologic surgical pathology. 4th ed. Philadelphia, PA: Elsevier; 2020.

    Google Scholar 

  • Cheng L, Davidson DD, Montironi R, et al. Fluorescence in situ hybridization (FISH) detection of chromosomal 12p anomalies in testicular germ cell yumors. Methods Mol Biol. 2021a;2195:49–63.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Mann SA, Lopez-Beltran A, et al. Molecular characterization of testicular germ cell tumors using tissue microdissection. Methods Mol Biol. 2021b;2195:31–47.

    Article  CAS  PubMed  Google Scholar 

  • Chovanec M, Cheng L. Molecular characterization of testicular germ cell tumors: chasing the underlying pathways. Future Oncol. 2019;15:227–9.

    Article  CAS  PubMed  Google Scholar 

  • Chovanec M, Cheng L. Advances in diagnosis and treatment of testicular cancer. BMJ. 2022;379:e070499.

    Article  PubMed  Google Scholar 

  • Emerson RE, Cheng L. Premalignancy of the testis and paratestis. Pathology. 2013;45:264–72.

    Article  PubMed  Google Scholar 

  • Heijnsdijk EAM, Supit SJ, Looijenga LHJ, et al. Screening for cancers with a good prognosis: the case of testicular germ cell cancer. Cancer Med. 2021;10:2897–903.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • King J, Adra N, Einhorn LH. Testicular cancer: biology to bedside. Cancer Res. 2021;81:5369–76.

    Article  CAS  PubMed  Google Scholar 

  • Kozakova K, Mego M, Cheng L, et al. Promising novel therapies for relapsed and refractory testicular germ cell tumors. Expert Rev Anticancer Ther. 2021;21:53–69.

    Article  CAS  PubMed  Google Scholar 

  • LeĂ£o R, Albersen M, Looijenga LHJ, et al. Circulating MicroRNAs, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review. Eur Urol. 2021;80:456–66.

    Article  PubMed  Google Scholar 

  • Lobo J, Gillis AJM, van den Berg A, et al. Identification and validation model for informative liquid biopsy-based microRNA biomarkers: insights from germ cell tumor in vitro, in vivo and patient-derived data. Cells. 2019;8:1637.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lobo J, van Zogchel LMJ, Nuru MG, et al. Combining hypermethylated RASSF1A detection using ddPCR with miR-371a-3p testing: an improved panel of liquid biopsy biomarkers for testicular germ cell tumor patients. Cancers (Basel). 2021;13:5228.

    Article  CAS  PubMed  Google Scholar 

  • Looijenga LH. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol. 2009;218:146–62.

    Article  PubMed  Google Scholar 

  • Looijenga LHJ, van der Kwast TH, Grignon D, et al. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors. Am J Surg Pathol. 2020;44:e66–79.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mohanty SK, Lobo A, Cheng L. The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges. Hum Pathol. 2023;136:123–43.

    Article  PubMed  Google Scholar 

  • Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5:210–22.

    Article  CAS  PubMed  Google Scholar 

  • Oosterhuis JW, Looijenga LHJ. Human germ cell tumours from a developmental perspective. Nat Rev Cancer. 2019;19:522–37.

    Article  CAS  PubMed  Google Scholar 

  • Roth LM, Cheng L. Mixed germ cell-sex cord stromal tumor of the testis with an intratubular component: a problem in differential diagnosis. Hum Pathol. 2016;51:51–6.

    Article  PubMed  Google Scholar 

  • Roth LM, Cheng L. On the histogenesis of mixed germ cell-sex cord stromal tumour of the gonads. J Clin Pathol. 2017;70:22–227.

    Article  Google Scholar 

  • Roth LM, Cheng L. Gonadoblastoma: origin and outcome. Hum Pathol. 2020;100:47–53.

    Article  CAS  PubMed  Google Scholar 

  • Roth LM, Lyu B, Cheng L. Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms. Hum Pathol. 2017;65:1–14.

    Article  PubMed  Google Scholar 

  • Shen H, Shih J, Hollern DP, et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep. 2018;23:3392–406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Timmerman DM, Remmers TL, Hillenius S, Looijenga LHJ. Mechanisms of TP53 pathway inactivation in embryonic and somatic cells-relevance for understanding (Germ Cell) tumorigenesis. Int J Mol Sci. 2021a;22:5377.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Timmerman DM, Gillis AJM, Mego M, Looijenga LHJ. Comparative analyses of liquid-biopsy microRNA371a-3p isolation protocols for serum and plasma. Cancers (Basel). 2021b;13:4260.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Timmerman DM, Eleveld TF, Sriram S, et al. Chromosome 3p25.3 gain is associated with cisplatin resistance and is an independent predictor of poor outcome in male malignant germ cell tumors. J Clin Oncol. 2022;40:3077–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Biermann, K., Cheng, L., Looijenga, L.H.J. (2023). Molecular Pathology of Testicular Cancer. In: Cheng, L., Netto, G.J., Eble, J.N. (eds) Molecular Surgical Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-35118-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-35118-1_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-35117-4

  • Online ISBN: 978-3-031-35118-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics